Nektar Therapeutics

Go to Nektar Therapeutics Website

$1.75

(%)
Live
Previous Close

$1.75

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$321.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The comp...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.

Related tickers: NKTR, LGND, ANIP.

Read Full Article

Nektar Therapeutics' rezpegaldesleukin is now in two phase 2 studies, one in atopic dermatitis and one in alopecia areata. See why NKTR stock is a Hold.

Related tickers: NKTR.

Read Full Article
Trending Tickers
FLGC

XNAS

$1.23
(%)
IBIT

XNAS

$39.97
(%)
LASE

XNAS

$2.28
(%)
MGAM

XNAS

$0.02
(%)
MLGO

XNAS

$2.30
(%)